Cambridge Healthtech Institute’s 15th Annual

Engineering Bispecific Antibodies

Achieving Unprecedented Efficacy

MAY 16 - 17, 2024 ALL TIMES EST


Incredible progress has been made to engineer bispecific antibodies using novel platforms and approaches to bring more molecules to the forefront of medicine that have the capacity to go beyond current limitations and advance cures for intractable diseases, including not only for oncology but also in infectious disease. Join this year’s luminary faculty at the 15th Annual Engineering Bispecific Antibodies: Achieving Unprecedented Efficacy conference at the PEGS Boston Summit, the original forum on this topic that showcases the advancement of engineering strategies for the creation of unique and efficacious bispecific antibody constructs.

Scientific Advisory Board
   Mahiuddin Ahmed, PhD, President and CSO, VITRUVIAE
   Shelley Force Aldred, PhD, CEO, Rondo Therapeutics
   Christian Klein, PhD, Cancer Immunotherapy Discovery, Roche Innovation Center Zurich,
   Roche Pharma Research & Early Development, pRED
   G. Jonah Rainey, PhD, Senior Director, Protein Engineering, Eli Lilly and Company
   Eugene Zhukovsky, PhD, Chief Scientific Officer, Ichnos Sciences

 






For more details on the conference, please contact:

Christina Lingham

Executive Director, Conferences and Fellow

Cambridge Healthtech Institute

Phone: 508-813-7570

Email: clingham@healthtech.com

 

For sponsorship information, please contact:

Companies A-K

Jason Gerardi

Senior Manager, Business Development

Cambridge Healthtech Institute

Phone: 781-972-5452

Email: jgerardi@healthtech.com

 

Companies L-Z

Ashley Parsons

Manager, Business Development

Cambridge Healthtech Institute

Phone: 781-972-1340

Email: ashleyparsons@healthtech.com


Register Now

View By:


Premier Sponsors

  Evitria_ag_companyLogo FairJourneyBiologics Integral-Molecular_NEWOmniAb   UnchainedLabs